Treatment

Tolinapant, Tolinapant clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
This study is testing a new medicine, Tolinapant, for people with advanced cancers like some solid tumours and lymphomas. The main goal is to check how safe it is and how the body handles the medicine. It also looks at whether the medicine helps to shrink tumours.
For: Advanced Solid Tumors and Lymphomas that are metastatic or unresectable: Cohort#1:Recurrent/metastatic head and neck squamous cell carcinoma · #2:Relapsed/refractory diffuse large B-cell lymphoma · #3:Progressive, refractory or relapsed peripheral T-cell lymphoma
Spain · Italy